cbdMD (YCBD) Capital Expenditures (2016 - 2025)
cbdMD (YCBD) posted Capital Expenditures of $164802.0 for Q4 2025, up 5777.39% sequentially from $2804.0 in Q3 2025, and little changed YoY from $164387.0 in Q4 2024.
cbdMD (YCBD) Capital Expenditures (2016 - 2025) Analysis & Trends
cbdMD has reported Capital Expenditures for 10 years, with the latest figure at $164802.0 in Q4 2025.
- Quarterly Capital Expenditures changed 0.25% year-over-year to $164802.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $184587.0 (up 8.73% YoY) and the FY2025 annual result came in at $184172.0, down 3.08% from the prior year.
- Capital Expenditures climbed to $164802.0 in Q4 2025 per YCBD's latest filing, from $2804.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $231030.0 in Q4 2021 and troughed at -$102390.0 in Q1 2023.
- A 5-year average of $93365.1 and a median of $102389.0 in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2023: Capital Expenditures surged 643.93% in 2022, then tumbled 171.72% in 2023.
- Over 5 years, Capital Expenditures stood at $231030.0 in 2021, then declined by 23.23% to $177370.0 in 2022, then advanced by 4.1% to $184635.0 in 2023, then dropped by 10.97% to $164387.0 in 2024, then gained by 0.25% to $164802.0 in 2025.
- According to Business Quant data, Capital Expenditures over the past three periods registered $164802.0, $2804.0, and $1475.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 164,802.00 |
| Dec 31, 2025 | 164,802.00 |
| Sep 30, 2025 | 2,804.00 |
| Sep 30, 2025 | 2,804.00 |
| Jun 30, 2025 | 1,475.00 |
| Jun 30, 2025 | 1,475.00 |
| Mar 31, 2025 | 15,506.00 |
| Mar 31, 2025 | 15,506.00 |
| Dec 31, 2024 | 164,387.00 |
| Dec 31, 2024 | 164,387.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Mar 31, 2024 | -4,620.00 |
| Mar 31, 2024 | -4,620.00 |
| Dec 31, 2023 | 184,635.00 |
| Dec 31, 2023 | 184,635.00 |
| Sep 30, 2023 | 120,180.00 |
| Sep 30, 2023 | 120,180.00 |
| Jun 30, 2023 | 102,389.00 |
| Jun 30, 2023 | 102,389.00 |